Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuroone Medical Technologies (NMTC) Free Cash Flow (2016 - 2026)

Neuroone Medical Technologies filings provide 15 years of Free Cash Flow readings, the most recent being -$1.4 million for Q1 2026.

  • On a quarterly basis, Free Cash Flow fell 2205.03% to -$1.4 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$7.6 million, a 52.73% decrease, with the full-year FY2025 number at -$2.9 million, up 73.78% from a year prior.
  • Free Cash Flow hit -$1.4 million in Q1 2026 for Neuroone Medical Technologies, up from -$3.2 million in the prior quarter.
  • In the past five years, Free Cash Flow ranged from a high of $951635.0 in Q3 2022 to a low of -$3.8 million in Q4 2023.
  • Median Free Cash Flow over the past 5 years was -$2.7 million (2022), compared with a mean of -$2.2 million.
  • Biggest five-year swings in Free Cash Flow: surged 146.1% in 2022 and later plummeted 2205.03% in 2026.
  • Neuroone Medical Technologies' Free Cash Flow stood at -$3.5 million in 2022, then fell by 9.78% to -$3.8 million in 2023, then surged by 104.77% to $183633.0 in 2024, then plummeted by 1818.97% to -$3.2 million in 2025, then skyrocketed by 56.69% to -$1.4 million in 2026.
  • The last three reported values for Free Cash Flow were -$1.4 million (Q1 2026), -$3.2 million (Q4 2025), and -$1.5 million (Q3 2025) per Business Quant data.